Mutation clearance and complete radiologic resolution of immunotherapy relapsed metastatic melanoma after treatment with nivolumab and olaparib in a patient with homologous recombinant deficiency: any role for PARP inhibitors and checkpoint blockade?

K. Khaddour, M. Ansstas, J. Visconti, G. Ansstas

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)279-280
Number of pages2
JournalAnnals of Oncology
Volume32
Issue number2
DOIs
StatePublished - Feb 2021

Cite this